224 related articles for article (PubMed ID: 11721650)
1. Treatment of systemic sclerosis.
Steen VD
Am J Clin Dermatol; 2001; 2(5):315-25. PubMed ID: 11721650
[TBL] [Abstract][Full Text] [Related]
2. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review.
Henness S; Wigley FM
Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543
[TBL] [Abstract][Full Text] [Related]
3. Treatment of systemic sclerosis.
Wigley FM
Curr Opin Rheumatol; 1992 Dec; 4(6):878-86. PubMed ID: 1457284
[TBL] [Abstract][Full Text] [Related]
4. Treatment Algorithms for Systemic Sclerosis According to Experts.
Fernández-Codina A; Walker KM; Pope JE;
Arthritis Rheumatol; 2018 Nov; 70(11):1820-1828. PubMed ID: 29781586
[TBL] [Abstract][Full Text] [Related]
5. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
Wigley FM; Seibold JR; Wise RA; McCloskey DA; Dole WP
J Rheumatol; 1992 Sep; 19(9):1407-14. PubMed ID: 1279170
[TBL] [Abstract][Full Text] [Related]
6. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
Colakoğlu M; Cobankara V; Akpolat T
Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574
[TBL] [Abstract][Full Text] [Related]
7. [Iloprost for the treatment of systemic sclerosis].
Hachulla E; Launay D; Hatron PY
Presse Med; 2008 May; 37(5 Pt 2):831-9. PubMed ID: 18035518
[TBL] [Abstract][Full Text] [Related]
8. Treatment of complications associated with systemic sclerosis.
Moore SC; Desantis ER
Am J Health Syst Pharm; 2008 Feb; 65(4):315-21. PubMed ID: 18238768
[TBL] [Abstract][Full Text] [Related]
9. Treatment of systemic sclerosis.
Pope J
Curr Opin Rheumatol; 1993 Nov; 5(6):792-801. PubMed ID: 7509616
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment of scleroderma.
Leighton C
Drugs; 2001; 61(3):419-27. PubMed ID: 11293650
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations of systemic sclerosis.
Steen VD
Semin Cutan Med Surg; 1998 Mar; 17(1):48-54. PubMed ID: 9512107
[TBL] [Abstract][Full Text] [Related]
13. Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years.
Bettoni L; Geri A; Airò P; Danieli E; Cavazzana I; Antonioli C; Chiesa L; Franceschini F; Grottolo A; Zambruni A; Radaeli E; Cattaneo R
Clin Rheumatol; 2002 Jun; 21(3):244-50. PubMed ID: 12111631
[TBL] [Abstract][Full Text] [Related]
14. Low versus high-dose iloprost therapy over 21 days in patients with secondary Raynaud's phenomenon and systemic sclerosis: a randomized, open, single-center study.
Kawald A; Burmester GR; Huscher D; Sunderkötter C; Riemekasten G
J Rheumatol; 2008 Sep; 35(9):1830-7. PubMed ID: 18634152
[TBL] [Abstract][Full Text] [Related]
15. Current treatment options in systemic Sclerosis (Scleroderma).
Stummvoll GH
Acta Med Austriaca; 2002; 29(1):14-9. PubMed ID: 11899748
[TBL] [Abstract][Full Text] [Related]
16. Management of Raynaud's phenomenon and digital ulcers in systemic sclerosis.
Botzoris V; Drosos AA
Joint Bone Spine; 2011 Jul; 78(4):341-6. PubMed ID: 21183379
[TBL] [Abstract][Full Text] [Related]
17. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.
Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR
Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476
[TBL] [Abstract][Full Text] [Related]
18. Systemic sclerosis.
Ng SC
Singapore Med J; 1992 Apr; 33(2):189-92. PubMed ID: 1621127
[TBL] [Abstract][Full Text] [Related]
19. Treatment of systemic sclerosis.
Pope JE
Rheum Dis Clin North Am; 1996 Nov; 22(4):893-907. PubMed ID: 8923602
[TBL] [Abstract][Full Text] [Related]
20. Raynaud, digital ulcers and calcinosis in scleroderma.
Nitsche A
Reumatol Clin; 2012; 8(5):270-7. PubMed ID: 22835924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]